製品 分子 DLEU Gene Deletion Detection Kit

DLEU Gene Deletion Detection Kit

Clinic Signification:
1.13q14 (DLEU gene) homozygous or heterozygous deletion is the most common abnormality in CLL (more than 60%), and the incidence rate in MM is 16-40%. The prognosis is poor.
2.DLEU gene deletion can also be seen in the detection of MAF/IGH fusion genes in tumors such as lymphoma/myeloma/prostate cancer/head and neck cancer/non-small cell lung cancer.

Contrast

DLEU Normal

DLEU Deletion

詳細

Probe Description: GSP DLEU /CSP13

Cat.No.: CF1270

Specification: 10 tests/box, 20 tests/box

関連製品

連絡してください

お問い合わせやフィードバックがある場合は、以下のフォームに記入して、チームにお問い合わせください。

トップ